1 |
Pérez A, Torregrosa I, D'Marco L, Juan I, Terradez L, Solís MÁ, Moncho F, Carda-Batalla C, Forner MJ, Gorriz JL. IgA-Dominant Infection-Associated Glomerulonephritis Following SARS-CoV-2 Infection. Viruses 2021;13:587. [PMID: 33807151 DOI: 10.3390/v13040587] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
2 |
Allinovi M, Bellinvia A, Pesce F, Milan Manani S, Razzolini L, Brezzi B, Protopapa P, Mantero V, Caroti L, Cirami CL, Amato MP, Del Vecchio L. Safety and Efficacy of Eculizumab Therapy in Multiple Sclerosis: A Case Series. Brain Sci 2021;11:1341. [PMID: 34679405 DOI: 10.3390/brainsci11101341] [Reference Citation Analysis]
|
3 |
Wang Y, Feng H, Nie X, Zhang Y, Zou L, Li X, Yu X, Zhao Y. Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy. Front Pharmacol 2022;13:907108. [DOI: 10.3389/fphar.2022.907108] [Reference Citation Analysis]
|